  Alterations in nuclear morphology are useful adjuncts and even diagnostic
tools used by pathologists in the diagnosis and grading of many tumors,
particularly malignant tumors. Large datasets such as TCGA and the Human
Protein Atlas, in combination with emerging machine learning and statistical
modeling methods, such as feature extraction and deep learning techniques, can
be used to extract meaningful knowledge from images of nuclei, particularly
from cancerous tumors. Here we describe a new technique based on the
mathematics of optimal transport for modeling the information content related
to nuclear chromatin structure directly from imaging data. In contrast to other
techniques, our method represents the entire information content of each
nucleus relative to a template nucleus using a transport-based morphometry
(TBM) framework. We demonstrate the model is robust to different staining
patterns and imaging protocols, and can be used to discover meaningful and
interpretable information within and across datasets and cancer types. In
particular, we demonstrate morphological differences capable of distinguishing
nuclear features along the spectrum from benign to malignant categories of
tumors across different cancer tissue types, including tumors derived from
liver parenchyma, thyroid gland, lung mesothelium, and skin epithelium. We
believe these proof of concept calculations demonstrate that the TBM framework
can provide the quantitative measurements necessary for performing meaningful
comparisons across a wide range of datasets and cancer types that can
potentially enable numerous cancer studies, technologies, and clinical
applications and help elevate the role of nuclear morphometry into a more
quantitative science. The source codes implementing our method is available at
https://github.com/rohdelab/nuclear_morphometry.
